Investor Presentaiton

9 INOVIO DNA Medicines Pipeline (Continued) PRODUCT INDICATION ANTIGEN PRECLINICAL PHASE 1 PHASE 2 PHASE 3 INFECTIOUS DISEASES (NON HPV-ASSOCIATED) PENNVAX-GP HIV Gag, pol, env INO-4201 Ebola INO-4700 MERS (GLS-5300) INO-4600 Zika (GLS-5700) Glycoprotein Spike Glycoprotein INO-4500 Lassa Fever Glycoprotein INO-4800 COVID-19 (Coronavirus) TM dMAb™ (DNA-ENCODED MONOCLONAL ANTIBODIES) INO-A002 Zika Spike Glycoprotein INTERNALLY FUNDED PARTNER/COLLABORATOR/FUNDER NIH NIAID HIV VACCINE TRIALS NETWORK DARPA GENE CEPI GENE CEPI CEPI BILL&MELINDA GATES foundation BILL& MELINDA GATES foundation EXTERNALLY FUNDED INOVIO POWERING DNA MEDICINES

View entire presentation